Barrier damage usually induces tissue repair mechanisms such as the IL-18-MYD88 axis, however in CRC, these cannot overcome the ongoing tissue damage caused by neoplastic tumor growth and a setting of chronic barrier impairment and inflammation becomes established (29, 30, 34). The gene discussed is IL18; the disease is neoplasm.